Traws Pharma, Inc.
TRAW
$0.83
-$0.01-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.51% | -87.86% | -333.01% | -104.26% | 171.82% |
| Total Depreciation and Amortization | 0.00% | 193.33% | 1,400.00% | 0.00% | -50.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 90.63% | 201.45% | 436.59% | 99.84% | -206.38% |
| Change in Net Operating Assets | -12.57% | 2,191.58% | 95.98% | -772.22% | -151.99% |
| Cash from Operations | 6.60% | 31.24% | 32.92% | -9.97% | -34.58% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -9.54% | 1,707.76% | -96.44% | 2,296.32% | -99.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -989.33% | -8.54% | -33.33% | -- |
| Cash from Financing | 1,100.63% | 354.84% | -102.00% | 23,707.69% | -99.93% |
| Foreign Exchange rate Adjustments | -- | 100.00% | -110.71% | 21.74% | 355.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.58% | 60.97% | -133.23% | 47.12% | -133.91% |